title: [Beneficial effect of thyrotropin-releasing hormone in combination with HSD on hemorrhagic shock with pulmonary edema at high altitude in the rat].
abstract: OBJECTIVE
  To study the effects of thyrotropin-releasing hormone (TRH) in combination with hypertonic saline/dextran (7.5% NaCl + 6% Dextran 40, HSD ) on hemorrhagic shock with pulmonary edema in the rats which were recently brought to high altitude.
  
  
  METHODS
  Forty-nine SD rats, transported to Lasa, Tibet, which was 3,760 meters above the sea level, were anesthetized one week later with sodium pentobarbital (30 mg/kg, intraperitoneal). Hemorrhagic shock with pulmonary edema was induced by hemorrhage (50 mm Hg maintained for 1 hour,1 mm Hg=0.133 kPa) plus intravenous injection of oleic acid (50 microl/kg). They were equally divided into seven groups (n=7): normal control, hemorrhagic shock, hemorrhagic shock with pulmonary edema (HSPE), HSPE plus TRH (5 mg/kg), HSPE plus HSD (4 ml/kg), and HEPE plus TRH and HSD in combination. Hemodynamic parameters including mean arterial blood pressure(MAP), left intraventricular systolic pressure (LVSP) and the maximal change rate of intraventricular pressure rise or decline (+/- dp/dt max) were observed at 15, 30, 60 and 120 minutes, blood gases were analyzed at 30 and 120 minutes, and the water content of lung and brain was determined at 120 minutes after drug administration.
  
  
  RESULTS
  TRH or HSD used alone or in combination significantly increased MAP, LVSP and +/- dp/dt max (P<0.05 or P<0.01 ), ameliorated acid-base imbalance, and decreased the water content of lung and brain. The effect of the two in combination was superior to either drug used alone.
  
  
  CONCLUSIONS
  TRH in combination with HSD can be used in the treatment of hemorrhagic shock with pulmonary edema at high altitude.
authors.affiliation: Research Institute of Surgery, Daping Hospital, the Third Military Medical University, Chongqing 400042, China.
authors.forename: De-yao
authors.initials: DY
authors.lastname: Hu
authors.forename: Liang-ming
authors.initials: LM
authors.lastname: Liu
authors.forename: Ping
authors.initials: P
authors.lastname: Li
authors.forename: Jian-cang
authors.initials: JC
authors.lastname: Liu
authors.forename: Hou-dong
authors.initials: HD
authors.lastname: Liu
authors.forename: Yan-mei
authors.initials: YM
authors.lastname: He
authors.forename: Xiao-ping
authors.initials: XP
authors.lastname: Huo
authors.forename: Kun-lun
authors.initials: KL
authors.lastname: Tian
authors.forename: Quan-gui
authors.initials: QG
authors.lastname: Shi
authors.forename: Nan
authors.initials: N
authors.lastname: Xiao
authors.forename: Xue-wu
authors.initials: XW
authors.lastname: Zhou
mesh_terms: D000531:Altitude; D000818:Animals; D011654:Pulmonary Edema / Q000150:complications / Q000188:drug therapy*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012462:Saline Solution, Hypertonic / Q000008:administration & dosage / Q000627:therapeutic use*; D012771:Shock, Hemorrhagic / Q000150:complications / Q000188:drug therapy*; D013973:Thyrotropin-Releasing Hormone / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D012462:Saline Solution, Hypertonic; D013973:Thyrotropin-Releasing Hormone